Key Insights
The European diabetic care devices market, valued at €8.03 billion in 2025, is projected to experience robust growth, driven by rising prevalence of diabetes, an aging population, and increasing awareness of advanced glucose monitoring and management technologies. The market's Compound Annual Growth Rate (CAGR) of 6.18% from 2025 to 2033 signifies substantial expansion, fueled by technological advancements in continuous glucose monitoring (CGM) systems, insulin pumps, and smart insulin delivery devices. These innovations offer improved diabetes management, enhanced patient convenience, and reduced healthcare costs in the long run. The market segmentation reveals significant contributions from self-monitoring blood glucose devices (SMBGs), representing a substantial portion of the market due to their widespread adoption and affordability. However, the CGM segment exhibits the fastest growth, reflecting increasing demand for real-time glucose data and proactive diabetes management. Further growth is anticipated from the adoption of advanced insulin delivery systems, such as insulin pumps and pen injectors, which offer greater precision and flexibility. Challenges to market growth include high device costs, particularly for CGMs and insulin pumps, potentially limiting accessibility for certain patient populations. Nevertheless, ongoing technological advancements and favorable reimbursement policies in several European countries are expected to mitigate these challenges and drive market expansion. The leading companies in this market, including Roche, Abbott, Medtronic, and Dexcom, are actively investing in research and development to enhance product offerings, expand market reach, and secure a competitive advantage. The European market is further segmented geographically with Germany, France, UK and Italy representing major markets due to their large diabetic populations and developed healthcare infrastructure.
The market's future trajectory hinges on several key factors. Further technological innovations, particularly in areas such as artificial pancreas systems and closed-loop insulin delivery, will significantly impact market growth. Regulatory approvals and reimbursement policies will play a crucial role in influencing the adoption of these advanced technologies. Furthermore, the growing focus on diabetes prevention and early intervention programs by European healthcare systems is expected to contribute to positive market dynamics. Finally, the rising prevalence of type 2 diabetes, linked to lifestyle factors such as obesity and sedentary behavior, will necessitate increased demand for effective diabetes management solutions, further driving market growth. Effective patient education programs and increased public awareness campaigns are expected to be instrumental in boosting market expansion, ensuring optimal utilization of the available technologies and improved health outcomes.
Europe Diabetic Care Devices Market: A Comprehensive Report (2019-2033)
This insightful report provides a comprehensive analysis of the Europe Diabetic Care Devices Market, offering a detailed overview of market trends, competitive landscape, and future growth prospects from 2019 to 2033. The study covers various segments including Self-monitoring Blood Glucose Devices, Continuous Glucose Monitoring Devices, Insulin Pumps, Insulin Syringes, and more, offering crucial insights for stakeholders across the value chain. With a base year of 2025 and a forecast period extending to 2033, this report is an invaluable resource for strategic decision-making. The market is estimated to be worth xx Million in 2025 and is projected to reach xx Million by 2033.
Europe Diabetic Care Devices Market Market Composition & Trends
This section meticulously dissects the European diabetic care devices market, evaluating its concentration, innovation drivers, regulatory environment, substitute products, end-user demographics, and mergers & acquisitions (M&A) activity. We analyze market share distribution across key players like Abbott Diabetes Care, Roche Diabetes Care, and Medtronic, revealing a dynamic competitive landscape. The report also assesses the impact of regulatory changes on market access and innovation, the influence of substitute products, and the role of M&A activities in shaping market consolidation. The average M&A deal value in the market is estimated to be xx Million.
- Market Concentration: Highly concentrated with top players holding significant market share.
- Innovation Catalysts: Advancements in CGM technology, miniaturization of insulin delivery devices, and development of smart devices are driving innovation.
- Regulatory Landscape: Stringent regulatory approvals influence market access and impact product development timelines.
- Substitute Products: Limited effective substitutes, but alternative therapies and management strategies pose some competitive pressure.
- End-User Profiles: Growing diabetic population, increasing prevalence of type 2 diabetes, and a rising elderly population are major end-user drivers.
- M&A Activities: Consolidation through acquisitions is expected to continue, driven by the desire to expand product portfolios and geographical reach.
Europe Diabetic Care Devices Market Industry Evolution
This section examines the evolution of the European diabetic care devices market, charting its growth trajectory, technological advancements, and evolving consumer preferences from 2019 to 2024. We analyze the factors driving market growth, including increased diabetes prevalence, technological advancements in continuous glucose monitoring (CGM) and insulin delivery systems, and improved patient awareness. We provide specific data points such as compound annual growth rates (CAGR) for different segments and adoption rates for new technologies. The market has experienced a CAGR of xx% during the historical period (2019-2024) and is expected to maintain a steady growth trajectory during the forecast period (2025-2033). Consumer demands are shifting towards more convenient, user-friendly, and integrated devices, influencing product development and market competition.
Leading Regions, Countries, or Segments in Europe Diabetic Care Devices Market
This section identifies the leading regions, countries, and segments within the European diabetic care devices market. Germany, France, and the UK are consistently among the leading countries due to high diabetes prevalence and robust healthcare infrastructure. Among device segments, CGM systems are experiencing rapid growth driven by technological improvements and increased patient preference for real-time glucose monitoring. Growth drivers are explored further for each of the leading segments and countries.
Key Drivers for Dominant Segments/Countries:
- Germany: Strong healthcare infrastructure, high diabetes prevalence, and significant government investment in diabetes management.
- France: Similar to Germany, France benefits from a well-developed healthcare system, significant investment in disease management, and higher diabetes prevalence.
- CGM Devices: Improved accuracy, ease of use, and the ability to provide real-time data significantly enhance patient outcomes and drive higher adoption rates.
- Insulin Pumps: Increased demand driven by superior glycemic control, convenience, and suitability for patients requiring multiple daily injections.
Dominance Factors: High diabetes prevalence, healthcare infrastructure quality, government support for diabetes management, and technological advancements are key dominance factors.
Europe Diabetic Care Devices Market Product Innovations
Recent product innovations have significantly improved the management of diabetes. The launch of innovative CGM systems offering enhanced accuracy, longer wear times, and remote monitoring capabilities is a significant trend. Miniaturization of insulin delivery devices and development of smart insulin pens offer improved user experience and better adherence to treatment plans. These advancements are driven by improvements in sensor technology, data analytics, and integration with mobile applications. The focus on ease of use and improved user interfaces is enhancing patient compliance and overall health outcomes.
Propelling Factors for Europe Diabetic Care Devices Market Growth
Several factors are driving growth in the European diabetic care devices market. Increased prevalence of diabetes across Europe is a primary driver, along with rising healthcare expenditure and government initiatives to improve diabetes management. Technological advancements such as the development of improved CGM sensors and more sophisticated insulin delivery systems are playing a crucial role in driving market growth. The increasing adoption of telemedicine and remote patient monitoring solutions is further expanding market opportunities.
Obstacles in the Europe Diabetic Care Devices Market Market
The European diabetic care devices market faces challenges including high device costs, reimbursement hurdles, and stringent regulatory requirements. Supply chain disruptions and the potential for counterfeit devices are also significant concerns. Furthermore, the market is highly competitive, with established players facing pressure from new entrants offering innovative products. These obstacles can limit market penetration and affect the growth trajectory.
Future Opportunities in Europe Diabetic Care Devices Market
Future opportunities lie in the development of advanced CGM systems with predictive capabilities and artificial intelligence integration. Closed-loop insulin delivery systems and integration with other digital health solutions offer significant growth potential. Expansion into underserved markets and the development of affordable, accessible devices can also create significant market opportunities.
Major Players in the Europe Diabetic Care Devices Market Ecosystem
- Rossmax
- Agamatrix Inc
- Roche Diabetes Care
- Bionime Corporation
- Sanofi
- Eli Lilly
- Novo Nordisk A/S
- Abbott Diabetes Care
- LifeScan
- Medtronic
- Dexcom Inc
- Ascensia Diabetes Care
- Insulet Corporation
Key Developments in Europe Diabetic Care Devices Market Industry
- February 2024: Dexcom launched its real-time CGM solution, Dexcom ONE+, in Europe. This customizable system offers improved convenience and user-friendliness.
- June 2022: Cequr launched its Insulin Pen 2.0™, a wearable insulin delivery device with an integrated blood glucose meter. This innovation combines convenience with enhanced monitoring capabilities.
Strategic Europe Diabetic Care Devices Market Market Forecast
The European diabetic care devices market is poised for significant growth, driven by continued technological advancements, an increasing diabetic population, and expanding healthcare infrastructure. The market is expected to witness substantial growth over the forecast period (2025-2033), with CGM systems and advanced insulin delivery technologies leading the growth trajectory. The market's future hinges on addressing challenges related to affordability and access while capitalizing on emerging technological trends.
Europe Diabetic Care Devices Market Segmentation
-
1. Monitoring Devices
-
1.1. Self-monitoring Blood Glucose Devices
- 1.1.1. Glucometer Devices
- 1.1.2. Blood Glucose Test Strips
- 1.1.3. Lancets
-
1.2. Continuous Glucose Monitoring Devices
- 1.2.1. Sensors
- 1.2.2. Durables (Receivers and Transmitters)
-
1.1. Self-monitoring Blood Glucose Devices
-
2. Management Devices
-
2.1. Insulin Pump
- 2.1.1. Insulin Pump Device
- 2.1.2. Insulin Pump Reservoir
- 2.1.3. Infusion Set
- 2.2. Insulin Syringes
- 2.3. Cartridges in Reusable Pens
- 2.4. Insulin Disposable Pens
- 2.5. Jet Injectors
-
2.1. Insulin Pump
Europe Diabetic Care Devices Market Segmentation By Geography
- 1. France
- 2. Germany
- 3. Italy
- 4. Spain
- 5. United Kingdom
- 6. Russia
- 7. Rest of Europe
Europe Diabetic Care Devices Market REPORT HIGHLIGHTS
| Aspects | Details |
|---|---|
| Study Period | 2019-2033 |
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2025-2033 |
| Historical Period | 2019-2024 |
| Growth Rate | CAGR of 6.18% from 2019-2033 |
| Segmentation |
|
Table of Contents
- 1. Introduction
- 1.1. Research Scope
- 1.2. Market Segmentation
- 1.3. Research Methodology
- 1.4. Definitions and Assumptions
- 2. Executive Summary
- 2.1. Introduction
- 3. Market Dynamics
- 3.1. Introduction
- 3.2. Market Drivers
- 3.2.1. Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income
- 3.3. Market Restrains
- 3.3.1. High Cost Associated with the Digital Dentistry
- 3.4. Market Trends
- 3.4.1. The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period
- 4. Market Factor Analysis
- 4.1. Porters Five Forces
- 4.2. Supply/Value Chain
- 4.3. PESTEL analysis
- 4.4. Market Entropy
- 4.5. Patent/Trademark Analysis
- 5. Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.1.1.1. Glucometer Devices
- 5.1.1.2. Blood Glucose Test Strips
- 5.1.1.3. Lancets
- 5.1.2. Continuous Glucose Monitoring Devices
- 5.1.2.1. Sensors
- 5.1.2.2. Durables (Receivers and Transmitters)
- 5.1.1. Self-monitoring Blood Glucose Devices
- 5.2. Market Analysis, Insights and Forecast - by Management Devices
- 5.2.1. Insulin Pump
- 5.2.1.1. Insulin Pump Device
- 5.2.1.2. Insulin Pump Reservoir
- 5.2.1.3. Infusion Set
- 5.2.2. Insulin Syringes
- 5.2.3. Cartridges in Reusable Pens
- 5.2.4. Insulin Disposable Pens
- 5.2.5. Jet Injectors
- 5.2.1. Insulin Pump
- 5.3. Market Analysis, Insights and Forecast - by Region
- 5.3.1. France
- 5.3.2. Germany
- 5.3.3. Italy
- 5.3.4. Spain
- 5.3.5. United Kingdom
- 5.3.6. Russia
- 5.3.7. Rest of Europe
- 5.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.1.1.1. Glucometer Devices
- 6.1.1.2. Blood Glucose Test Strips
- 6.1.1.3. Lancets
- 6.1.2. Continuous Glucose Monitoring Devices
- 6.1.2.1. Sensors
- 6.1.2.2. Durables (Receivers and Transmitters)
- 6.1.1. Self-monitoring Blood Glucose Devices
- 6.2. Market Analysis, Insights and Forecast - by Management Devices
- 6.2.1. Insulin Pump
- 6.2.1.1. Insulin Pump Device
- 6.2.1.2. Insulin Pump Reservoir
- 6.2.1.3. Infusion Set
- 6.2.2. Insulin Syringes
- 6.2.3. Cartridges in Reusable Pens
- 6.2.4. Insulin Disposable Pens
- 6.2.5. Jet Injectors
- 6.2.1. Insulin Pump
- 6.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.1.1.1. Glucometer Devices
- 7.1.1.2. Blood Glucose Test Strips
- 7.1.1.3. Lancets
- 7.1.2. Continuous Glucose Monitoring Devices
- 7.1.2.1. Sensors
- 7.1.2.2. Durables (Receivers and Transmitters)
- 7.1.1. Self-monitoring Blood Glucose Devices
- 7.2. Market Analysis, Insights and Forecast - by Management Devices
- 7.2.1. Insulin Pump
- 7.2.1.1. Insulin Pump Device
- 7.2.1.2. Insulin Pump Reservoir
- 7.2.1.3. Infusion Set
- 7.2.2. Insulin Syringes
- 7.2.3. Cartridges in Reusable Pens
- 7.2.4. Insulin Disposable Pens
- 7.2.5. Jet Injectors
- 7.2.1. Insulin Pump
- 7.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.1.1.1. Glucometer Devices
- 8.1.1.2. Blood Glucose Test Strips
- 8.1.1.3. Lancets
- 8.1.2. Continuous Glucose Monitoring Devices
- 8.1.2.1. Sensors
- 8.1.2.2. Durables (Receivers and Transmitters)
- 8.1.1. Self-monitoring Blood Glucose Devices
- 8.2. Market Analysis, Insights and Forecast - by Management Devices
- 8.2.1. Insulin Pump
- 8.2.1.1. Insulin Pump Device
- 8.2.1.2. Insulin Pump Reservoir
- 8.2.1.3. Infusion Set
- 8.2.2. Insulin Syringes
- 8.2.3. Cartridges in Reusable Pens
- 8.2.4. Insulin Disposable Pens
- 8.2.5. Jet Injectors
- 8.2.1. Insulin Pump
- 8.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9. Spain Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.1.1.1. Glucometer Devices
- 9.1.1.2. Blood Glucose Test Strips
- 9.1.1.3. Lancets
- 9.1.2. Continuous Glucose Monitoring Devices
- 9.1.2.1. Sensors
- 9.1.2.2. Durables (Receivers and Transmitters)
- 9.1.1. Self-monitoring Blood Glucose Devices
- 9.2. Market Analysis, Insights and Forecast - by Management Devices
- 9.2.1. Insulin Pump
- 9.2.1.1. Insulin Pump Device
- 9.2.1.2. Insulin Pump Reservoir
- 9.2.1.3. Infusion Set
- 9.2.2. Insulin Syringes
- 9.2.3. Cartridges in Reusable Pens
- 9.2.4. Insulin Disposable Pens
- 9.2.5. Jet Injectors
- 9.2.1. Insulin Pump
- 9.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.1.1.1. Glucometer Devices
- 10.1.1.2. Blood Glucose Test Strips
- 10.1.1.3. Lancets
- 10.1.2. Continuous Glucose Monitoring Devices
- 10.1.2.1. Sensors
- 10.1.2.2. Durables (Receivers and Transmitters)
- 10.1.1. Self-monitoring Blood Glucose Devices
- 10.2. Market Analysis, Insights and Forecast - by Management Devices
- 10.2.1. Insulin Pump
- 10.2.1.1. Insulin Pump Device
- 10.2.1.2. Insulin Pump Reservoir
- 10.2.1.3. Infusion Set
- 10.2.2. Insulin Syringes
- 10.2.3. Cartridges in Reusable Pens
- 10.2.4. Insulin Disposable Pens
- 10.2.5. Jet Injectors
- 10.2.1. Insulin Pump
- 10.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11. Russia Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.1.1.1. Glucometer Devices
- 11.1.1.2. Blood Glucose Test Strips
- 11.1.1.3. Lancets
- 11.1.2. Continuous Glucose Monitoring Devices
- 11.1.2.1. Sensors
- 11.1.2.2. Durables (Receivers and Transmitters)
- 11.1.1. Self-monitoring Blood Glucose Devices
- 11.2. Market Analysis, Insights and Forecast - by Management Devices
- 11.2.1. Insulin Pump
- 11.2.1.1. Insulin Pump Device
- 11.2.1.2. Insulin Pump Reservoir
- 11.2.1.3. Infusion Set
- 11.2.2. Insulin Syringes
- 11.2.3. Cartridges in Reusable Pens
- 11.2.4. Insulin Disposable Pens
- 11.2.5. Jet Injectors
- 11.2.1. Insulin Pump
- 11.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.1.1.1. Glucometer Devices
- 12.1.1.2. Blood Glucose Test Strips
- 12.1.1.3. Lancets
- 12.1.2. Continuous Glucose Monitoring Devices
- 12.1.2.1. Sensors
- 12.1.2.2. Durables (Receivers and Transmitters)
- 12.1.1. Self-monitoring Blood Glucose Devices
- 12.2. Market Analysis, Insights and Forecast - by Management Devices
- 12.2.1. Insulin Pump
- 12.2.1.1. Insulin Pump Device
- 12.2.1.2. Insulin Pump Reservoir
- 12.2.1.3. Infusion Set
- 12.2.2. Insulin Syringes
- 12.2.3. Cartridges in Reusable Pens
- 12.2.4. Insulin Disposable Pens
- 12.2.5. Jet Injectors
- 12.2.1. Insulin Pump
- 12.1. Market Analysis, Insights and Forecast - by Monitoring Devices
- 13. Germany Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 14. France Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 15. Italy Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 16. United Kingdom Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 17. Netherlands Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 18. Sweden Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 19. Rest of Europe Europe Diabetic Care Devices Market Analysis, Insights and Forecast, 2019-2031
- 20. Competitive Analysis
- 20.1. Market Share Analysis 2024
- 20.2. Company Profiles
- 20.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
- 20.2.1.1. Overview
- 20.2.1.2. Products
- 20.2.1.3. SWOT Analysis
- 20.2.1.4. Recent Developments
- 20.2.1.5. Financials (Based on Availability)
- 20.2.2 Agamatrix Inc
- 20.2.2.1. Overview
- 20.2.2.2. Products
- 20.2.2.3. SWOT Analysis
- 20.2.2.4. Recent Developments
- 20.2.2.5. Financials (Based on Availability)
- 20.2.3 Self-monitoring Blood Glucose Devices
- 20.2.3.1. Overview
- 20.2.3.2. Products
- 20.2.3.3. SWOT Analysis
- 20.2.3.4. Recent Developments
- 20.2.3.5. Financials (Based on Availability)
- 20.2.4 Roche Diabetes Care
- 20.2.4.1. Overview
- 20.2.4.2. Products
- 20.2.4.3. SWOT Analysis
- 20.2.4.4. Recent Developments
- 20.2.4.5. Financials (Based on Availability)
- 20.2.5 Bionime Corporation
- 20.2.5.1. Overview
- 20.2.5.2. Products
- 20.2.5.3. SWOT Analysis
- 20.2.5.4. Recent Developments
- 20.2.5.5. Financials (Based on Availability)
- 20.2.6 Sanofi
- 20.2.6.1. Overview
- 20.2.6.2. Products
- 20.2.6.3. SWOT Analysis
- 20.2.6.4. Recent Developments
- 20.2.6.5. Financials (Based on Availability)
- 20.2.7 Eli Lilly
- 20.2.7.1. Overview
- 20.2.7.2. Products
- 20.2.7.3. SWOT Analysis
- 20.2.7.4. Recent Developments
- 20.2.7.5. Financials (Based on Availability)
- 20.2.8 Novo Nordisk A/S
- 20.2.8.1. Overview
- 20.2.8.2. Products
- 20.2.8.3. SWOT Analysis
- 20.2.8.4. Recent Developments
- 20.2.8.5. Financials (Based on Availability)
- 20.2.9 Abbott Diabetes Care
- 20.2.9.1. Overview
- 20.2.9.2. Products
- 20.2.9.3. SWOT Analysis
- 20.2.9.4. Recent Developments
- 20.2.9.5. Financials (Based on Availability)
- 20.2.10 LifeScan
- 20.2.10.1. Overview
- 20.2.10.2. Products
- 20.2.10.3. SWOT Analysis
- 20.2.10.4. Recent Developments
- 20.2.10.5. Financials (Based on Availability)
- 20.2.11 Medtronic
- 20.2.11.1. Overview
- 20.2.11.2. Products
- 20.2.11.3. SWOT Analysis
- 20.2.11.4. Recent Developments
- 20.2.11.5. Financials (Based on Availability)
- 20.2.12 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES
- 20.2.12.1. Overview
- 20.2.12.2. Products
- 20.2.12.3. SWOT Analysis
- 20.2.12.4. Recent Developments
- 20.2.12.5. Financials (Based on Availability)
- 20.2.13 Insulin Device
- 20.2.13.1. Overview
- 20.2.13.2. Products
- 20.2.13.3. SWOT Analysis
- 20.2.13.4. Recent Developments
- 20.2.13.5. Financials (Based on Availability)
- 20.2.14 Dexcom Inc
- 20.2.14.1. Overview
- 20.2.14.2. Products
- 20.2.14.3. SWOT Analysis
- 20.2.14.4. Recent Developments
- 20.2.14.5. Financials (Based on Availability)
- 20.2.15 Continuous Glucose Monitoring Devices
- 20.2.15.1. Overview
- 20.2.15.2. Products
- 20.2.15.3. SWOT Analysis
- 20.2.15.4. Recent Developments
- 20.2.15.5. Financials (Based on Availability)
- 20.2.16 Ascensia Diabetes Care
- 20.2.16.1. Overview
- 20.2.16.2. Products
- 20.2.16.3. SWOT Analysis
- 20.2.16.4. Recent Developments
- 20.2.16.5. Financials (Based on Availability)
- 20.2.17 Insulet Corporation
- 20.2.17.1. Overview
- 20.2.17.2. Products
- 20.2.17.3. SWOT Analysis
- 20.2.17.4. Recent Developments
- 20.2.17.5. Financials (Based on Availability)
- 20.2.1 Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS
List of Figures
- Figure 1: Europe Diabetic Care Devices Market Revenue Breakdown (Million, %) by Product 2024 & 2032
- Figure 2: Europe Diabetic Care Devices Market Share (%) by Company 2024
List of Tables
- Table 1: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 2: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 3: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 4: Europe Diabetic Care Devices Market Revenue Million Forecast, by Region 2019 & 2032
- Table 5: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 6: Germany Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 7: France Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 8: Italy Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 9: United Kingdom Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 10: Netherlands Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 11: Sweden Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 12: Rest of Europe Europe Diabetic Care Devices Market Revenue (Million) Forecast, by Application 2019 & 2032
- Table 13: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 14: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 15: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 16: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 17: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 18: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 19: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 20: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 21: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 22: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 23: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 24: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 25: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 26: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 27: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 28: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 29: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 30: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
- Table 31: Europe Diabetic Care Devices Market Revenue Million Forecast, by Monitoring Devices 2019 & 2032
- Table 32: Europe Diabetic Care Devices Market Revenue Million Forecast, by Management Devices 2019 & 2032
- Table 33: Europe Diabetic Care Devices Market Revenue Million Forecast, by Country 2019 & 2032
Frequently Asked Questions
1. What is the projected Compound Annual Growth Rate (CAGR) of the Europe Diabetic Care Devices Market?
The projected CAGR is approximately 6.18%.
2. Which companies are prominent players in the Europe Diabetic Care Devices Market?
Key companies in the market include Rossmax*List Not Exhaustive 7 2 COMPANY SHARE ANALYSIS, Agamatrix Inc, Self-monitoring Blood Glucose Devices, Roche Diabetes Care, Bionime Corporation, Sanofi, Eli Lilly, Novo Nordisk A/S, Abbott Diabetes Care, LifeScan, Medtronic, 7 COMPETITIVE LANDSCAPE7 1 COMPANY PROFILES, Insulin Device, Dexcom Inc, Continuous Glucose Monitoring Devices, Ascensia Diabetes Care, Insulet Corporation.
3. What are the main segments of the Europe Diabetic Care Devices Market?
The market segments include Monitoring Devices, Management Devices.
4. Can you provide details about the market size?
The market size is estimated to be USD 8.03 Million as of 2022.
5. What are some drivers contributing to market growth?
Increasing Demand for Better Dentistry and Better Aesthetic outcomes; Increase in the Disposable Income.
6. What are the notable trends driving market growth?
The continuous glucose monitoring segment is expected to witness the highest growth rate over the forecast period.
7. Are there any restraints impacting market growth?
High Cost Associated with the Digital Dentistry.
8. Can you provide examples of recent developments in the market?
Feburary 2024: Dexcom launched real-time CGM solution Dexcom ONE+ in Europe. Dexcom ONE+ is a customisable continuous glucose monitoring solution that can be worn at three different location on the body.
9. What pricing options are available for accessing the report?
Pricing options include single-user, multi-user, and enterprise licenses priced at USD 4750, USD 5250, and USD 8750 respectively.
10. Is the market size provided in terms of value or volume?
The market size is provided in terms of value, measured in Million.
11. Are there any specific market keywords associated with the report?
Yes, the market keyword associated with the report is "Europe Diabetic Care Devices Market," which aids in identifying and referencing the specific market segment covered.
12. How do I determine which pricing option suits my needs best?
The pricing options vary based on user requirements and access needs. Individual users may opt for single-user licenses, while businesses requiring broader access may choose multi-user or enterprise licenses for cost-effective access to the report.
13. Are there any additional resources or data provided in the Europe Diabetic Care Devices Market report?
While the report offers comprehensive insights, it's advisable to review the specific contents or supplementary materials provided to ascertain if additional resources or data are available.
14. How can I stay updated on further developments or reports in the Europe Diabetic Care Devices Market?
To stay informed about further developments, trends, and reports in the Europe Diabetic Care Devices Market, consider subscribing to industry newsletters, following relevant companies and organizations, or regularly checking reputable industry news sources and publications.
Methodology
Step 1 - Identification of Relevant Samples Size from Population Database
Step 2 - Approaches for Defining Global Market Size (Value, Volume* & Price*)
Note*: In applicable scenarios
Step 3 - Data Sources
Primary Research
- Web Analytics
- Survey Reports
- Research Institute
- Latest Research Reports
- Opinion Leaders
Secondary Research
- Annual Reports
- White Paper
- Latest Press Release
- Industry Association
- Paid Database
- Investor Presentations
Step 4 - Data Triangulation
Involves using different sources of information in order to increase the validity of a study
These sources are likely to be stakeholders in a program - participants, other researchers, program staff, other community members, and so on.
Then we put all data in single framework & apply various statistical tools to find out the dynamic on the market.
During the analysis stage, feedback from the stakeholder groups would be compared to determine areas of agreement as well as areas of divergence
